Clinical Trial Update: TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer

View source ↗

Summary

A Mayo Clinic-sponsored clinical trial seeks to characterize TRPC6 to predict and prevent chemotherapy-related cardiomyopathy and heart failure in breast cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cardiomyopathy
• Heart Failure

Snippet

Sponsor: Mayo Clinic | Conditions: Breast Carcinoma, Cardiomyopathy | Status: RECRUITING